Preoperative predictors and prognosis of bilateral multifocal papillary thyroid carcinomas. 2019

Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
Yildirim Beyazit University, Ataturk Education and Research Hospital, Endocrinology and Metabolism Department, Ankara, Turkey. Electronic address: burcakugurlu@gmail.com.

BACKGROUND The characteristics of multifocal PTC remain controversial. Surgical approach to multifocal tumor changes between centers. This study aimed to evaluate the incidence of bilateral involvement, predictive factors for bilaterality and whether bilaterality was related with more aggressive histopathologic features or prognosis in patients with multifocal PTC. METHODS Medical records and pathologic data of 914 patients who underwent total thyroidectomy and diagnosed with PTC were retrospectively reviewed. The patients with multifocal disease were detected and divided into two subgroups as unilateral-multifocal PTCs and bilateral multifocal PTCs. Those two groups were compared regarding to demographic, clinical and histopathological features. RESULTS Multifocal disease was detected in 294 patients (32.7%). Of all, 102 patients (36.7%) had unilateral whereas 192 cases (65.3%) had bilateral involvement. As a result of univariate analysis, bilaterality was significantly associated with the number of tumor foci (p < 0.001), tumor size (p = 0.008), TSH (p = 0.002) and capsule invasion (p = 0.018). Multivariate analysis demonstrated that the number of tumor foci and TSH level were independent risk factors for bilaterality in multifocal PTC (p < 0.001 and p = 0.006, respectively). Bilateral and unilateral tumors had similar local/regional and distant recurrence rates. CONCLUSIONS Incidence of bilateral tumors is high and increases with the number of tumor foci in multifocal PTC. Bilateral involvement in multifocal PTC is not associated with worse prognosis.TSH can be taken as a preoperative indicator able to predict multifocal cancers and guide clinical decision making and surgical management.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012372 ROC Curve A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli. ROC Analysis,Receiver Operating Characteristic,Analysis, ROC,Analyses, ROC,Characteristic, Receiver Operating,Characteristics, Receiver Operating,Curve, ROC,Curves, ROC,ROC Analyses,ROC Curves,Receiver Operating Characteristics

Related Publications

Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
April 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
January 2013, International journal of endocrinology,
Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
January 1982, Virchows Archiv. A, Pathological anatomy and histology,
Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
January 2022, Acta endocrinologica (Bucharest, Romania : 2005),
Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
January 2018, Case reports in medicine,
Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
September 2010, Human pathology,
Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
February 2018, Medicine,
Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
April 2006, Clinical cancer research : an official journal of the American Association for Cancer Research,
Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
September 2005, The New England journal of medicine,
Sefika Burcak Polat, and Bekir Cakir, and Berna Evranos, and Husniye Baser, and Neslihan Cuhaci, and Cevdet Aydin, and Reyhan Ersoy
September 2005, The New England journal of medicine,
Copied contents to your clipboard!